News & Media

Read more about the article Q&A with Pepper Bio Senior Computational Biologist, Sam Roth
Blog

Q&A with Pepper Bio Senior Computational Biologist, Sam Roth

Please welcome the newest member of the Pepper Bio team, Sam Roth! Sam joins us from a role at Fulcrum Therapeutics, where he focused on developing computational methods for analyzing NGS data with the aim of target discovery in rare genetic disease. Sam’s first day at Pepper as a Senior Computational Biologist was just over a week ago. You can learn more about why Sam joined our team, as well…

Comments Off on Q&A with Pepper Bio Senior Computational Biologist, Sam Roth
March 17, 2023
Podcast

Podcast: Making Science Open to All

There are very few sciences Dr. Strasser hasn't studied, from mathematics to engineering and biology. Now she is the CSO of Pepper Bio, a drug discovery company that uses AI and other clever algorithms to treat patients more effectively. In short, Dr. Strasser is using her gifts to help others and it was inspiring and right-sizing to speak with such a humble trailblazer. Listen here to learn how Pepper is…

Comments Off on Podcast: Making Science Open to All
March 7, 2023
Read more about the article Startup Pepper Bio Touts ‘Transomics’ as Key Strategy in its Drug Discovery Efforts
Blog

Startup Pepper Bio Touts ‘Transomics’ as Key Strategy in its Drug Discovery Efforts

Reposted from Neil Versel, Editor at GenomeWeb CHICAGO – While multiomics seems to be a top biotech buzzword these days, drug discovery and bioinformatics startup Pepper Bio is trying to make a name for itself in the field of transomics. To that end, the Boston-based startup is leveraging support from Merck and other entities as part of an accelerator program to try and hone its strategy for applications such as…

Comments Off on Startup Pepper Bio Touts ‘Transomics’ as Key Strategy in its Drug Discovery Efforts
January 19, 2023
Read more about the article Ex-Phio VP, Simon Fricker, Joins Pepper Bio As Chief Development Officer
News

Ex-Phio VP, Simon Fricker, Joins Pepper Bio As Chief Development Officer

By Jon Hu, CEO and Cofounder of Pepper Bio  Pepper Bio, the world’s first transomics drug discovery company, announced the addition of Simon Fricker, Ph.D., as chief development officer. Previously, Dr. Fricker served three years as vice president of research and development at Phio Pharmaceuticals, a publicly-traded clinical-stage biotechnology company, and eight years as a distinguished scientific fellow at Genzyme/Sanofi. In his new role at Pepper, Dr. Fricker will support the…

Comments Off on Ex-Phio VP, Simon Fricker, Joins Pepper Bio As Chief Development Officer
December 14, 2022
Podcast

Podcast: Transforming Drug Discovery Through the Emerging Discipline of Transomics

Samantha Dale Strasser has always wanted to make a positive impact on humanity, and this desire was intensified while in grad school when her father was diagnosed with frontal temporal dementia — an illness with no effective treatments. Never afraid to ask the hard questions, this personal experience propelled her academic and biotech career toward driving science to address unmet medical needs. Using her skills in biomedical engineering, computer science,…

Comments Off on Podcast: Transforming Drug Discovery Through the Emerging Discipline of Transomics
September 28, 2022
Podcast

Podcast: Transomic Data Analysis Driving New Understanding of Diseases

Dr. Samantha Dale Strasser, Chief Scientific Officer and Co-Founder at Pepper Bio, uses a transomic perspective with a global functional causal lens on genomic data to drive insights throughout the drug discovery process and identify the best treatments for patients. The goal is to go beyond the traditional understanding of diseases to unlock opportunities and solutions not considered in the past. Samantha explains, "So, I mentioned the genome is fantastic because…

Comments Off on Podcast: Transomic Data Analysis Driving New Understanding of Diseases
September 15, 2022